Deborah A. Zarin

7.3k total citations · 1 hit paper
97 papers, 4.8k citations indexed

About

Deborah A. Zarin is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Statistics, Probability and Uncertainty. According to data from OpenAlex, Deborah A. Zarin has authored 97 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 34 papers in Economics and Econometrics and 31 papers in Statistics, Probability and Uncertainty. Recurrent topics in Deborah A. Zarin's work include Meta-analysis and systematic reviews (31 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Ethics in Clinical Research (25 papers). Deborah A. Zarin is often cited by papers focused on Meta-analysis and systematic reviews (31 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Ethics in Clinical Research (25 papers). Deborah A. Zarin collaborates with scholars based in United States, Canada and United Kingdom. Deborah A. Zarin's co-authors include Tony Tse, Rebecca J. Williams, Nicholas C. Ide, Joyce C. West, Robert M. Califf, Julie M. Zito, Harold Alan Pincus, Mark Olfson, Harold Alan Pincus and Steven C. Marcus and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Deborah A. Zarin

95 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ClinicalTrials.gov Results Database — Update and Key Issues

2011 547 citations Deborah A. Zarin, Tony Tse et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Deborah A. Zarin

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Zarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Zarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Zarin more than expected).

Fields of papers citing papers by Deborah A. Zarin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Zarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Zarin. The network helps show where Deborah A. Zarin may publish in the future.

Co-authorship network of co-authors of Deborah A. Zarin

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Zarin. A scholar is included among the top collaborators of Deborah A. Zarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Zarin. Deborah A. Zarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of key information sections in informed consent forms posted on ClinicalTrials.gov 2023 ·Journal of Clinical and Translational Science ·Luke Gelinas, (unknown), Tony Tse, (unknown), Deborah A. Zarin, Barbara E. Bierer	3
2	How to limit uninformative trials: Results from a Delphi working group 2023 ·Med ·Luke Gelinas, (unknown), Deborah A. Zarin, Barbara E. Bierer	2
3	Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis 2022 ·BMJ ·(unknown), (unknown), Tony Tse, (unknown), David S. Loose, Gisele Sarosy, Sheila A. Prindiville, Frank W. Rockhold, Deborah A. Zarin	3
4	Issues in the registration of database studies 2020 ·Journal of Clinical Epidemiology ·Deborah A. Zarin, William H. Crown, Barbara E. Bierer	7
5	Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS) 2016 ·PLoS Medicine ·Deborah A. Zarin, Tony Tse	33
6	Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination 2015 ·PLoS ONE ·Rebecca J. Williams, Tony Tse, (unknown), Deborah A. Zarin	146
7	Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis 2012 ·BMJ ·Joseph S. Ross, Tony Tse, Deborah A. Zarin, Hong Xu, Lixin Zhou, Harlan M. Krumholz	265
8	Reporting “Basic Results” in ClinicalTrials.gov 2009 ·CHEST Journal ·Tony Tse, Rebecca Williams, Deborah A. Zarin	89
9	Trial Registration at ClinicalTrials.gov between May and October 2005 2005 ·New England Journal of Medicine ·Deborah A. Zarin, Tony Tse, Nicholas C. Ide	209
10	A systematic review of pneumatic compression for treatment of chronic venous insufficiency and venous ulcers 2003 ·Journal of Vascular Surgery ·Elise Berliner, (unknown), Deborah A. Zarin	60
11	Risk-Benefit Decision Making for Treatment of Depression During Pregnancy 2000 ·American Journal of Psychiatry ·Katherine L. Wisner, Deborah A. Zarin, Eric S. Holmboe, Paul S. Appelbaum, Alan J. Gelenberg, Henrietta L. Leonard, Ellen Frank	185
12	Managed care and fee discounts in psychiatry: New evidence 2000 ·The Journal of Behavioral Health Services & Research ·Bowen Garrett, Richard M. Scheffler, Deborah A. Zarin, Harold Alan Pincus	5
13	Psychiatric Patients and Treatments in 1997 1999 ·Archives of General Psychiatry ·Harold Alan Pincus, Deborah A. Zarin, Terri Tanielian, (unknown), Joyce C. West, Amy R. Pettit, Steven C. Marcus, Ronald C. Kessler, John S. McIntyre	100
14	Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder 1999 ·Archives of Pediatrics and Adolescent Medicine ·Julie M. Zito, Daniel J. Safer, Susan dosReis, Laurence S. Magder, James F. Gardner, Deborah A. Zarin	137
15	Prescribing Trends in Psychotropic Medications 1998 ·JAMA ·Harold Alan Pincus, Terri Tanielian, Steven C. Marcus, Mark Olfson, Deborah A. Zarin, (unknown), Julie M. Zito	322
16	Clinical and Treatment Characteristics of Children With Attention-Deficit/Hyperactivity Disorder in Psychiatric Practice 1998 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Deborah A. Zarin, (unknown), Harold Alan Pincus, (unknown), Julie M. Zito	67
17	Assessing the feasibility of recruiting a randomly selected sample of psychiatrists to participate in a national practice-based research network 1998 ·Social Psychiatry and Psychiatric Epidemiology ·Joyce C. West, Deborah A. Zarin, Brennan Peterson, Harold Alan Pincus	17
18	Practice settings and sources of patient-care income of psychiatrists in early, mid, and late career 1997 ·Psychiatric Services ·Deborah A. Zarin, Brennan Peterson, Ana Suárez, Harold Alan Pincus, (unknown), (unknown)	10
19	Practice-based research in psychiatry 1997 ·American Journal of Psychiatry ·Deborah A. Zarin, Harold Alan Pincus, Joyce C. West, John S. McIntyre	68
20	Decision Analysis as a Basis for Medical Decision Making: The Tree of Hippocrates 1984 ·The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine ·Deborah A. Zarin, Stephen G. Pauker	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact